title: Atypical presentation of therapy-related acute promyelocytic leukaemia with marrow fibrosis.
authors.affiliation: Launceston General Hospital, Launceston, Australia; University of Tasmania, Launceston, Tas, Australia. Electronic address: muhajirbm@yahoo.com.
authors.forename: Muhajir
authors.initials: M
authors.lastname: Mohamed
authors.affiliation: Royal Prince Alfred Hospital, Camperdown, NSW, Australia; University of Sydney, Sydney, NSW, Australia.
authors.forename: Harry J
authors.initials: HJ
authors.lastname: Iland
authors.affiliation: Launceston General Hospital, Launceston, Australia.
authors.forename: Sharad
authors.initials: S
authors.lastname: Sharma
authors.affiliation: Royal Prince Alfred Hospital, Camperdown, NSW, Australia.
authors.forename: Shane G
authors.initials: SG
authors.lastname: Supple
mesh_terms: D000208:Acute Disease; D000230:Adenocarcinoma / Q000188:drug therapy* / Q000628:therapy; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000069287:Capecitabine / Q000009:adverse effects / Q000627:therapeutic use; D059248:Chemoradiotherapy; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000628:therapy; D005260:Female; D006801:Humans; D015255:Idarubicin / Q000627:therapeutic use; D015473:Leukemia, Promyelocytic, Acute / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology / Q000473:pathology; D008875:Middle Aged; D016609:Neoplasms, Second Primary / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology / Q000473:pathology; D009944:Organoplatinum Compounds / Q000009:adverse effects / Q000627:therapeutic use; D000077150:Oxaliplatin; D010198:Pancytopenia; D055728:Primary Myelofibrosis / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology / Q000473:pathology; D012074:Remission Induction; D014212:Tretinoin / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D009944:Organoplatinum Compounds; D000077150:Oxaliplatin; D014212:Tretinoin; D000069287:Capecitabine; D015255:Idarubicin